Found: 31
Select item for more details and to access through your institution.
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 6, p. 855, doi. 10.1007/s00428-023-03634-2
- By:
- Publication type:
- Article
A new era of the Asian clinical research network: a report from the ATLAS international symposium.
- Published in:
- Japanese Journal of Clinical Oncology, 2023, v. 53, n. 7, p. 619, doi. 10.1093/jjco/hyad033
- By:
- Publication type:
- Article
Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions.
- Published in:
- Japanese Journal of Clinical Oncology, 2018, v. 48, n. 1, p. 82, doi. 10.1093/jjco/hyx153
- By:
- Publication type:
- Article
Changes in HER3 expression profiles between primary and recurrent gynecological cancers.
- Published in:
- Cancer Cell International, 2023, p. 1, doi. 10.1186/s12935-022-02844-z
- By:
- Publication type:
- Article
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 287, doi. 10.1007/s10549-022-06787-x
- By:
- Publication type:
- Article
Clinical Application of Comprehensive Genomic Profiling Tests for Diffuse Gliomas.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2454, doi. 10.3390/cancers14102454
- By:
- Publication type:
- Article
Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.732525
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 596, doi. 10.1002/cpt.1817
- By:
- Publication type:
- Article
A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 4, p. 803, doi. 10.1002/cpt.1442
- By:
- Publication type:
- Article
Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 3, p. 491, doi. 10.1002/cpt.1453
- By:
- Publication type:
- Article
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 4, p. 568, doi. 10.1038/s41416-022-02072-2
- By:
- Publication type:
- Article
Comprehensive screening for drugs that modify radiation-induced immune responses.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 12, p. 1815, doi. 10.1038/s41416-021-01688-0
- By:
- Publication type:
- Article
Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 12, p. 2040, doi. 10.3390/diagnostics13122040
- By:
- Publication type:
- Article
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
- Published in:
- Oncology, 2022, v. 100, n. 7, p. 370, doi. 10.1159/000524500
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12200
- By:
- Publication type:
- Article
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.
- Published in:
- Oncology Letters, 2020, v. 20, n. 4, p. N.PAG
- By:
- Publication type:
- Article
Disseminated herpes zoster infection initially presenting with abdominal pain in patients with lymphoma undergoing conventional chemotherapy: A report of three cases.
- Published in:
- Oncology Letters, 2016, v. 12, n. 2, p. 809, doi. 10.3892/ol.2016.4683
- By:
- Publication type:
- Article
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1157789
- By:
- Publication type:
- Article
Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia.
- Published in:
- Cancer Science, 2023, v. 114, n. 6, p. 2664, doi. 10.1111/cas.15790
- By:
- Publication type:
- Article
Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose‐finding trials.
- Published in:
- Cancer Science, 2018, v. 109, n. 1, p. 207, doi. 10.1111/cas.13436
- By:
- Publication type:
- Article
Drug induced interstitial lung disease in oncology phase I trials.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1830, doi. 10.1111/cas.13087
- By:
- Publication type:
- Article
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37616-w
- By:
- Publication type:
- Article
Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography.
- Published in:
- 2019
- By:
- Publication type:
- journal article
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e82
- By:
- Publication type:
- Article
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1037, doi. 10.1007/s12282-024-01617-y
- By:
- Publication type:
- Article
Comparison of the efficacy of trastuzumab emtansine between patients with metastatic human epidermal growth factor receptor 2-positive breast cancers previously treated with combination trastuzumab and pertuzumab and with trastuzumab only in Japanese population
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 4, p. 492, doi. 10.1007/s12282-019-00949-4
- By:
- Publication type:
- Article